Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Neoleukin Therapeutics, Inc. (AQXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/03/2023 SC 13G PICTET ASSET MANAGEMENT SA reports a 0% stake in Neoleukin Therapeutics Inc.
12/30/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/19/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/15/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/07/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2022 SC 13G PICTET ASSET MANAGEMENT SA reports a 6.1% stake in Neoleukin Therapeutics Inc.
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/12/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/12/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/02/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2020 SC 13G Ulge Umut reports a 8.2% stake in Neoleukin Therapeutics, Inc.
02/13/2020 SC 13G Silva Manzano Daniel Adriano reports a 8.2% stake in Neoleukin Therapeutics, Inc.
12/27/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/16/2018 SC 13G EcoR1 Capital, LLC reports a 7.5% stake in Aquinox Pharmaceuticals, Inc.
10/11/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/16/2016 SC 13G Ventures West 8 Limited Partnership reports a 5.9% stake in Aquinox Pharmaceuticals Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy